New blinded preliminary safety and efficacy data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in podium presentation on ...

Allows for the processing of allogeneic (non-autologous) donor tissue material, including stem cells, for medical research –MELVILLE, N.Y., ...